Cafepharma Today

July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dynavax Technologies shares drop as the company files FDA response over hepatitis B drug
Yahoo/AP
Friday, September 19, 2008 - 8:48am
tags:
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Yahoo
Friday, September 19, 2008 - 8:39am
tags:
Celgene Becomes a Bargain Once Again
Seeking Alpha
Friday, September 19, 2008 - 8:38am
tags:
Chugai Pharma Falls After Actemra Approval Delay
Bloomberg
Friday, September 19, 2008 - 8:37am
tags:
Elan Shares Rise on Survey Showing MS Drug Sales Won't Plunge
Bloomberg
Friday, September 19, 2008 - 8:36am
tags:
Qwest, Amgen Scrap Deals, Pay 14% Amid Credit Crisis
Bloomberg
Friday, September 19, 2008 - 8:35am
tags:
Pfizer Is A Driver: "Complaining" Investor Read On!
CNBC
Thursday, September 18, 2008 - 4:56pm
tags:
Vertex Pharma slips after saying it will raise $191.3 million in cash through stock sale
Yahoo/AP
Thursday, September 18, 2008 - 4:12pm
tags:
Obama, McCain advisers agree...on generic drugs
Yahoo/AP
Thursday, September 18, 2008 - 4:11pm
tags:
Medical Device Makers Throwing Money Down the Tube
Motley Fool
Thursday, September 18, 2008 - 4:09pm
tags:
Statistics Smackdown: Experts Duel Over Vytorin Cancer Data
WSJ Online
Thursday, September 18, 2008 - 4:09pm
tags:
Lilly Loves Lechleiter--But Stock Moves On Other "News"
CNBC
Thursday, September 18, 2008 - 4:08pm
tags:
J&J Fairly Earns Its Premium
Yahoo/Zacks.com
Thursday, September 18, 2008 - 9:32am
tags:
Vertex Pharma prices offering at $25.50 a share
Marketwatch
Thursday, September 18, 2008 - 9:31am
tags:
Vertex Pharma's Ebb & Flow
Trading Markets
Thursday, September 18, 2008 - 8:45am
tags:
Patients Transitioned From Fosamax(R) To Denosumab Achieved Greater Gains In Bone Mineral Density Vs Those Continuing On Alendronate
Medical News Today
Thursday, September 18, 2008 - 8:44am
tags:
Merck KGaA starts new Phase III trial on MS pill
Reuters
Thursday, September 18, 2008 - 8:22am
tags:
AstraZeneca, Pfizer eye Karo Bio
News Journal, DE
Thursday, September 18, 2008 - 8:21am
tags:
Mylan's Generic Expectations
Trading Markets
Thursday, September 18, 2008 - 8:13am
tags:
Study: Drug for serious psoriasis tops competition
Yahoo/AP
Thursday, September 18, 2008 - 8:12am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Crafting Effective, Patient-Centric Channel Strategies
Drug Channels
Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers
Drug Channels
Optimizing Product Commercialization in Today’s IDN Environment
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Drug Channels
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
Drug Channels
Breaking Down Medication Access and Affordability Barriers
Drug Channels
Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School
Drug Channels
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Drug Channels

Latest Jobs

Account Executive - Hospice
Freeman, Missouri, 64746
Agape Care Group
Account Executive - Hospice
Wellington, Missouri, 64097
Agape Care Group
Account Executive - Hospice
Napoleon, Missouri, 64074
Agape Care Group
Healthcare Sales Professional
Denton, Texas, Texas
Tris Pharma
Psychiatry Account Manager - Santa Monica, CA
Santa Monica, California
Lundbeck
Senior Account Consultant, Durysta - San Diego, CA
San Diego, California, California
AbbVie
Senior Account Consultant, Retina - Hartford, CT
New Haven, Connecticut, Connecticut
AbbVie
Oncology Specialist - New York City
New York City, New York
AbbVie
Associate Director, Strategic Account Manager, Southern California
Los Angeles, California, California
AbbVie
Oncology Specialist - LA West
Santa Monica, California
AbbVie
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information